Eliot M. Lurier
2021
In 2021, Eliot M. Lurier earned a total compensation of $25.9K as Interim Chief Financial Officer at Tenax Therapeutics.
Compensation breakdown
| Other | $25,900 |
|---|---|
| Total | $25,900 |
Lurier received $25.9K in other compensation, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Eliot M. Lurier's compensation ranked 12,347th out of 12,415 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,347 out of 12,415 | 1st |
Division Manufacturing | 5,476 out of 5,505 | 1st |
Major group Chemicals And Allied Products | 2,369 out of 2,375 | 0th |
Industry group Drugs | 2,090 out of 2,096 | 0th |
Industry Pharmaceutical Preparations | 1,543 out of 1,546 | 0th |
Source: SEC filing on April 28, 2022.
Lurier's colleagues
We found four more compensation records of executives who worked with Eliot M. Lurier at Tenax Therapeutics in 2021.